Semaglutide Market Insights, Global Outlook and Forecast 2022-2028
Semaglutide Market Insights, Global Outlook and Forecast 2022-2028
Semaglutide Market by End User (Office Building Construction, Retail Construction, Hospitality Construction, Institutional Construction, Other End Users), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast - is a comprehensive report that provides insights into the market dynamics, including the key drivers, challenges, and opportunities shaping the industry landscape. It also delves into the competitive landscape, highlighting the major players and their strategies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Semaglutide (trade names Rybelsus, Ozempic) is a medication for the treatment of type 2 diabetes. Side effects include medullary thyroid cancer, kidney problems, diabetic retinopathy, allergic reactions, low blood sugar, and pancreatitis. Semaglutide acts like human glucagon-like peptide-1 (GLP-1) so that it increases insulin secretion, thereby increasing sugar metabolism. It is distributed as a metered subcutaneous injection in a prefilled pen. One of its advantages over other antidiabetic drugs is that it has a long duration of action, thus, only once-a-week injection is sufficient. An injection version was approved in 2017 in the United States, and in Europe, Canada, and Japan in 2018. An version which is taken by mouth was approved in 2019 in the United States. It is the first glucagon-like peptide (GLP-1) receptor protein treatment approved for use in the United States that does not need to be injected. It was developed by the Danish company Novo Nordisk.
The latest research study released by Market IntelliX evaluates market size and forecasts of Semaglutide in global, including the following market information:
Global Semaglutide Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Semaglutide Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Semaglutide companies in 2021 (%)
The global Semaglutide market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Semaglutide include Novo Nordisk. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Semaglutide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Semaglutide Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Semaglutide Market Segment Percentages, by Type, 2021 (%)
Injection
Oral
Global Semaglutide Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Semaglutide Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Global Semaglutide Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Semaglutide Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Semaglutide revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Semaglutide revenues share in global market, 2021 (%)
Key companies Semaglutide sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Semaglutide sales share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Novo Nordisk
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Semaglutide Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Semaglutide Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Semaglutide Overall Market Size
2.1 Global Semaglutide Market Size: 2021 VS 2028
2.2 Global Semaglutide Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Semaglutide Sales: 2017-2028
3 Company Landscape
3.1 Top Semaglutide Players in Global Market
3.2 Top Global Semaglutide Companies Ranked by Revenue
3.3 Global Semaglutide Revenue by Companies
3.4 Global Semaglutide Sales by Companies
3.5 Global Semaglutide Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Semaglutide Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Semaglutide Product Type
3.8 Tier 1, Tier 2 and Tier 3 Semaglutide Players in Global Market
3.8.1 List of Global Tier 1 Semaglutide Companies
3.8.2 List of Global Tier 2 and Tier 3 Semaglutide Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Semaglutide Market Size Markets, 2021 & 2028
4.1.2 Injection
4.1.3 Oral
4.2 By Type - Global Semaglutide Revenue & Forecasts
4.2.1 By Type - Global Semaglutide Revenue, 2017-2022
4.2.2 By Type - Global Semaglutide Revenue, 2023-2028
4.2.3 By Type - Global Semaglutide Revenue Market Share, 2017-2028
4.3 By Type - Global Semaglutide Sales & Forecasts
4.3.1 By Type - Global Semaglutide Sales, 2017-2022
4.3.2 By Type - Global Semaglutide Sales, 2023-2028
4.3.3 By Type - Global Semaglutide Sales Market Share, 2017-2028
4.4 By Type - Global Semaglutide Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Semaglutide Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Semaglutide Revenue & Forecasts
5.2.1 By Application - Global Semaglutide Revenue, 2017-2022
5.2.2 By Application - Global Semaglutide Revenue, 2023-2028
5.2.3 By Application - Global Semaglutide Revenue Market Share, 2017-2028
5.3 By Application - Global Semaglutide Sales & Forecasts
5.3.1 By Application - Global Semaglutide Sales, 2017-2022
5.3.2 By Application - Global Semaglutide Sales, 2023-2028
5.3.3 By Application - Global Semaglutide Sales Market Share, 2017-2028
5.4 By Application - Global Semaglutide Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Semaglutide Market Size, 2021 & 2028
6.2 By Region - Global Semaglutide Revenue & Forecasts
6.2.1 By Region - Global Semaglutide Revenue, 2017-2022
6.2.2 By Region - Global Semaglutide Revenue, 2023-2028
6.2.3 By Region - Global Semaglutide Revenue Market Share, 2017-2028
6.3 By Region - Global Semaglutide Sales & Forecasts
6.3.1 By Region - Global Semaglutide Sales, 2017-2022
6.3.2 By Region - Global Semaglutide Sales, 2023-2028
6.3.3 By Region - Global Semaglutide Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Semaglutide Revenue, 2017-2028
6.4.2 By Country - North America Semaglutide Sales, 2017-2028
6.4.3 US Semaglutide Market Size, 2017-2028
6.4.4 Canada Semaglutide Market Size, 2017-2028
6.4.5 Mexico Semaglutide Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Semaglutide Revenue, 2017-2028
6.5.2 By Country - Europe Semaglutide Sales, 2017-2028
6.5.3 Germany Semaglutide Market Size, 2017-2028
6.5.4 France Semaglutide Market Size, 2017-2028
6.5.5 U.K. Semaglutide Market Size, 2017-2028
6.5.6 Italy Semaglutide Market Size, 2017-2028
6.5.7 Russia Semaglutide Market Size, 2017-2028
6.5.8 Nordic Countries Semaglutide Market Size, 2017-2028
6.5.9 Benelux Semaglutide Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Semaglutide Revenue, 2017-2028
6.6.2 By Region - Asia Semaglutide Sales, 2017-2028
6.6.3 China Semaglutide Market Size, 2017-2028
6.6.4 Japan Semaglutide Market Size, 2017-2028
6.6.5 South Korea Semaglutide Market Size, 2017-2028
6.6.6 Southeast Asia Semaglutide Market Size, 2017-2028
6.6.7 India Semaglutide Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Semaglutide Revenue, 2017-2028
6.7.2 By Country - South America Semaglutide Sales, 2017-2028
6.7.3 Brazil Semaglutide Market Size, 2017-2028
6.7.4 Argentina Semaglutide Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Semaglutide Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Semaglutide Sales, 2017-2028
6.8.3 Turkey Semaglutide Market Size, 2017-2028
6.8.4 Israel Semaglutide Market Size, 2017-2028
6.8.5 Saudi Arabia Semaglutide Market Size, 2017-2028
6.8.6 UAE Semaglutide Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Corporate Summary
7.1.2 Novo Nordisk Business Overview
7.1.3 Novo Nordisk Semaglutide Major Product Offerings
7.1.4 Novo Nordisk Semaglutide Sales and Revenue in Global (2017-2022)
7.1.5 Novo Nordisk Key News
8 Global Semaglutide Production Capacity, Analysis
8.1 Global Semaglutide Production Capacity, 2017-2028
8.2 Semaglutide Production Capacity of Key Manufacturers in Global Market
8.3 Global Semaglutide Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Semaglutide Supply Chain Analysis
10.1 Semaglutide Industry Value Chain
10.2 Semaglutide Upstream Market
10.3 Semaglutide Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Semaglutide Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Research Methodology:
Semaglutide Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|